Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants

Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010

(2011) H. C. J. Ertl et al.   CANCER RESEARCH

Enhancement of T-cell-Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer

(2011) R. P. M. Dings et al.   CLINICAL CANCER RESEARCH

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

(2011) Timothy Kottke et al.   NATURE MEDICINE

Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know

(2011) Steven A. Rosenberg   Nature Reviews Clinical Oncology

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

(2011) David L. Porter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adoptive Cell Therapy

(2010) Richard A. Morgan et al.   CANCER JOURNAL

Molecular Mechanism of MART-1 + /A*0201 + Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor–CTL Interaction

(2010) Ali R. Jazirehi et al.   CANCER RESEARCH

Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

(2010) Isabel Maleno et al.   IMMUNOGENETICS

Immune evasion of microsatellite unstable colorectal cancers

(2010) Matthias Kloor et al.   INTERNATIONAL JOURNAL OF CANCER

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

(2010) Peter J. Campbell et al.   NATURE

Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy

(2009) A. G. Ramsay et al.   BLOOD

HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses

(2009) A. P. Lepique et al.   CLINICAL CANCER RESEARCH

Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1

(2009) Ferenc Kovács-Sólyom et al.   IMMUNOLOGY LETTERS

Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction

(2009) S. Biswas et al.   JOURNAL OF IMMUNOLOGY

Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients

(2009) Michal J. Besser et al.   JOURNAL OF IMMUNOTHERAPY

Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones

(2009) Amir Khammari et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

(2008) K. Movahedi et al.   BLOOD

Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape

(2008) O. Goldberger et al.   CANCER RESEARCH

Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

(2008) Rafael Carretero et al.   IMMUNOGENETICS

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

(2008) Mark E. Dudley et al.   JOURNAL OF CLINICAL ONCOLOGY